Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Status:
Terminated
Trial end date:
2017-08-20
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects of donor stem cell transplant in treating
patients with high risk acute myeloid leukemia. Giving low doses of chemotherapy before a
donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may
also stop the patient's immune system from rejecting the donor's stem cells when they do not
exactly match the patient's blood. The donated stem cells may replace the patient's immune
cells and help destroy any remaining cancer cells (graft-versus-tumor effect)